Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Section Content Menu
Skip to Common Links
Enter Search terms
A-Z Index
Home
Food
Drugs
Medical Devices
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Radiation-Emitting Products
Tobacco Products
-
Drugs
Share
Email this page
Home
>
Drugs
>
Guidance, Compliance & Regulatory Information
>
Guidances (Drugs)
Section Contents Menu
Guidance, Compliance & Regulatory Information
Guidances (Drugs)
Advertising
Biopharmaceutics
CMC - Microbiology (Chemistry, Manufacturing, and Controls)
Chemistry, Manufacturing, and Controls (CMC)
Clinical / Antimicrobial
Clinical / Medical
Clinical Pharmacology
Combination Products
Concept Papers
Current Good Manufacturing Practices (CGMPs)/Compliance
Drug Safety
Electronic Submissions
FDAAA (Food and Drug Administration Amendments Act)
Generics
Good Review Practices
Individual Product Bioequivalence Recommendations
Industry Letters
International Conference on Harmonisation - Efficacy
International Conference on Harmonisation - Joint Safety/Efficacy (Multidisciplinary)
International Conference on Harmonisation - Quality
International Conference on Harmonisation - Safety
Investigational New Drug Applications
Labeling
Microbiology
Modernization Act
Over-the-Counter
Pharm / Tox
Procedural
Small Entity Compliance Guides
User Fees
-
Clinical / Antimicrobial
Title and Format
Type
Issue Date
Acute Bacterial Exacerbations of Chronic Bronchitis in Patients with Chronic Obstructive Pulmonary Disease: Developing Antimicrobial Drugs for Treatment(PDF - 422 KB)
Draft
8/21/2008
Acute Bacterial Meningitis — Developing Antimicrobial Drugs for Treatment(PDF - 42 KB)
Draft
7/22/1998
Acute Bacterial Sinusitis — Developing Antimicrobial Drugs for Treatment (PDF - 155 KB)
Draft
10/29/2007
Acute or Chronic Bacterial Prostatitis — Developing Antimicrobial Drugs for Treatment (PDF - 42 KB)
Draft
7/22/1998
Acute Bacterial Otitis Media: Developing Drugs for Treatment (PDF - 173 KB)
Draft
1/17/2008
Antibacterial Drug Products: Use of Noninferiority Studies to Support Approval (PDF - 41 KB)
Draft
10/12/2007
Antiviral Product Development--Conducting and Submitting Virology Studies to the Agency (PDF - 208 KB)
Guidance for Submitting HIV Resistance Data (PDF - 293 KB)
Guidance for Submitting Influenza Resistance Data (PDF - 385 KB)
Guidance for Submitting HBV Resistance Data (PDF - 123 KB)
Guidance for Submitting HCV Resistance Data (PDF - 122 KB)
Final
6/2/2006
Antiretroviral Drugs Using Plasma HIV RNA Measurements — Clinical Considerations for Accelerated and Traditional Approval (PDF - 254 KB)
Final
10/2002
Bacterial Vaginosis — Developing Antimicrobial Drugs for Treatment (PDF - 53 KB)
Draft
7/22/1998
Catheter-Related Bloodstream Infections - Developing Antimicrobial Drugs for Treatment (PDF - 54 KB)
Draft
10/1999
Clinical Development and Labeling of Anti-Infective Drug Products (PDF - 5 MB)
Final
10/1992 Revised 2/12/2001
Clinical Evaluation of Anti-Infective Drugs (Systemic)(PDF - 1 MB)
Final
9/77
Community-Acquired Bacterial Pneumonia: Developing Drugs for Treatment (PDF - 418 KB)
Draft
3/19/2009
Complicated Urinary Tract Infections and Pyelonephritis — Developing Antimicrobial Drugs for Treatment (PDF - 35 KB)
Draft
7/22/1998
Developing Antimicrobial Drugs — General Considerations for Clinical Trials (PDF - 134 KB)
[Main Document]
Draft
7/22/1998
Developing Antimicrobial Drugs to Treat Inhalational Anthrax (Post Exposure) -- (PDF - 51 KB)
Draft
3/15/2002
Empiric Therapy of Febrile Neutropenia — Developing Antimicrobial Drugs for Treatment (PDF - 33 KB)
Draft
7/22/1998
Evaluating Clinical Studies Of Antimicrobials In The Division Of Anti-Infective Drug Products (PDF - 267 KB)
Draft
2/18/1997
Helicobacter pylori-Associated Duodenal Ulcer Disease in Adults: Developing Drugs for Treatment (PDF - 145 KB)
Draft
10/2/2009
Influenza: Developing Drugs for Treatment and/or Prophylaxis(PDF - 225 KB)
Draft
2/19/2009
Lyme Disease — Developing Antimicrobial Drugs for Treatment (PDF - 42 KB)
Draft
7/22/1998
Microbiological Data for Systemic Antibacterial Drug Products — Development, Analysis, and Presentation (PDF - 272 KB)
Draft
9/16/2009
Nosocomial Pneumonia — Developing Antimicrobial Drugs for Treatment (PDF - 49 KB)
Draft
7/22/1998
Role of HIV Drug Resistance Testing in Antiretroviral Drug Development (PDF - 244 KB)
Final
10/30/2007
Secondary Bacterial Infections of Acute Bronchitis — Developing Antimicrobial Drugs for Treatment (PDF - 10 KB)
Draft
7/22/1998
Smallpox (Variola) Infection: Developing Drugs for Treatment or Prevention (PDF - 257 KB)
Draft
11/21/2007
Streptococcal Pharyngitis and Tonsillitis — Developing Antimicrobial Drugs for Treatment (PDF - 29 KB)
Draft
7/22/1998
Uncomplicated and Complicated Skin and Skin Structure Infections — Developing Antimicrobial Drugs for Treatment (PDF - 49 KB)
Draft
7/22/1998
Uncomplicated Gonorrhea — Developing Antimicrobial Drugs for Treatment (PDF - 30 KB)
Draft
7/22/1998,
Uncomplicated Urinary Tract Infections — Developing Antimicrobial Drugs for Treatment (PDF - 42 KB)
Draft
7/22/1998
Vaccinia Virus — Developing Drugs to Mitigate Complications from Smallpox Vaccination (PDF - 139 KB)
Draft
3/8/2004
Vulvovaginal Candidiasis — Developing Antimicrobial Drugs for Treatment (PDF - 42 KB)
Draft
7/22/1998
-
-
-
-
-